Vascular Endothelial Growth Factor Receptor-2, antagonists & inhibitors

Name
Vascular Endothelial Growth Factor Receptor-2, antagonists & inhibitors
Accession Number
DBCAT001653
Description
Not Available
Drugs
DrugDrug Description
PegdinetanibInvestigated for use/treatment in cancer/tumors (unspecified) and macular degeneration.
TesevatinibTesevatinib has been used in trials studying the treatment of Cancer, Stomach Cancer, Brain Metastases, Esophageal Cancer, and Leptomeningeal Metastases, among others. Tesevatinib is a potent inhibitor of multiple RTKs...
GolvatinibGolvatinib has been investigated for the treatment of Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck.
Drugs & Drug Targets
DrugTargetType
PegdinetanibVascular endothelial growth factor receptor 2target
TesevatinibPro-epidermal growth factortarget
TesevatinibEphrin type-B receptor 4target
TesevatinibReceptor tyrosine-protein kinase erbB-2target